SEC Form 4 · accession 0001140361-26-032332
FEMASYS INC · FEMY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Gerald Mifek
Officer — Chief Clinical-Medical Affairs
Period of report
Jul 6, 2026
Accepted (ET)
Aug 11, 2026 · 8:51 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001339005
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.08 | Jul 6, 2026 | A | 6,250 | A | — | Jul 6, 2036 | Common Stock | 6,250 | 6,250 | D |
Explanation of responses
- F1The shares underlying the stock option vest equally in installments over 4 years beginning on July 6, 2027, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date.